Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders - PubMed (original) (raw)
Review
Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders
V Papadopoulos et al. Neuroscience. 2006.
Abstract
The peripheral-type benzodiazepine receptor is a mitochondrial protein expressed at high levels in steroid synthesizing tissues, including the glial cells of the brain. Peripheral-type benzodiazepine receptor binds cholesterol with high affinity and is a key element of the cholesterol mitochondrial import machinery responsible for supplying the substrate cholesterol to the first steroidogenic enzyme, thus initiating and maintaining neurosteroid biosynthesis. Neurosteroid formation and metabolism of steroid intermediates are critical components of normal brain function. Peripheral-type benzodiazepine receptor also binds with high affinity various classes of compounds. Upon ligand activation peripheral-type benzodiazepine receptor-dependent cholesterol transport into mitochondria is accelerated leading in increased formation of neuroactive steroids. These steroids, such as allopregnanolone, have been shown to be involved in various neurological disorders, such as anxiety and mood disorders. Thus, peripheral-type benzodiazepine receptor drug ligand-induced neuroactive steroid formation offers a means to regulate brain dysfunction. Peripheral-type benzodiazepine receptor basal expression is upregulated in a number of neuropathologies, including gliomas and neurodegenerative disorders, as well as in various forms of brain injury and inflammation. In Alzheimer's disease pathology neurosteroid biosynthesis is altered and a decrease in the intermediate 22R-hydroxycholesterol levels is observed. This steroid was found to exert neuroprotective properties against beta-amyloid neurotoxicity. Based on this observation, a stable spirostenol derivative showing to display neuroprotective properties was identified, suggesting that compounds developed based on critical intermediates of neurosteroid biosynthesis could offer novel means for neuroprotection. In conclusion, changes in peripheral-type benzodiazepine receptor and neurosteroid levels are part of the phenotype seen in neuropathology and neurological disorders and offer potential targets for new therapies.
Similar articles
- Peripheral benzodiazepine receptor: structure and function in health and disease.
Papadopoulos V. Papadopoulos V. Ann Pharm Fr. 2003 Jan;61(1):30-50. Ann Pharm Fr. 2003. PMID: 12589253 Review. - Structure, function and regulation of the mitochondrial peripheral-type benzodiazepine receptor.
Papadopoulos V, Amri H, Li H, Yao Z, Brown RC, Vidic B, Culty M. Papadopoulos V, et al. Therapie. 2001 Sep-Oct;56(5):549-56. Therapie. 2001. PMID: 11806292 Review. - Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties.
Papadopoulos V, Lecanu L. Papadopoulos V, et al. J Neuroendocrinol. 2012 Jan;24(1):93-101. doi: 10.1111/j.1365-2826.2011.02167.x. J Neuroendocrinol. 2012. PMID: 21623958 Review. - Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines.
Veenman L, Levin E, Weisinger G, Leschiner S, Spanier I, Snyder SH, Weizman A, Gavish M. Veenman L, et al. Biochem Pharmacol. 2004 Aug 15;68(4):689-98. doi: 10.1016/j.bcp.2004.05.011. Biochem Pharmacol. 2004. PMID: 15276076 - Neurosteroids: biosynthesis and function of these novel neuromodulators.
Compagnone NA, Mellon SH. Compagnone NA, et al. Front Neuroendocrinol. 2000 Jan;21(1):1-56. doi: 10.1006/frne.1999.0188. Front Neuroendocrinol. 2000. PMID: 10662535 Review.
Cited by
- Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma.
Aebisher D, Woźnicki P, Czarnecka-Czapczyńska M, Dynarowicz K, Szliszka E, Kawczyk-Krupka A, Bartusik-Aebisher D. Aebisher D, et al. Int J Mol Sci. 2024 Aug 9;25(16):8708. doi: 10.3390/ijms25168708. Int J Mol Sci. 2024. PMID: 39201395 Free PMC article. Review. - Integrated Approach for Testing and Assessment for Developmental Neurotoxicity (DNT) to Prioritize Aromatic Organophosphorus Flame Retardants.
Kreutz A, Oyetade OB, Chang X, Hsieh JH, Behl M, Allen DG, Kleinstreuer NC, Hogberg HT. Kreutz A, et al. Toxics. 2024 Jun 18;12(6):437. doi: 10.3390/toxics12060437. Toxics. 2024. PMID: 38922117 Free PMC article. - Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry.
Barresi E, Robello M, Baglini E, Poggetti V, Viviano M, Salerno S, Da Settimo F, Taliani S. Barresi E, et al. Pharmaceuticals (Basel). 2023 Jul 12;16(7):997. doi: 10.3390/ph16070997. Pharmaceuticals (Basel). 2023. PMID: 37513909 Free PMC article. Review. - Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer's Disease.
Afsar A, Chacon Castro MDC, Soladogun AS, Zhang L. Afsar A, et al. Int J Mol Sci. 2023 Apr 14;24(8):7258. doi: 10.3390/ijms24087258. Int J Mol Sci. 2023. PMID: 37108421 Free PMC article. Review. - Analysis of Wild Type and Variant B Cystatin C Interactome in Retinal Pigment Epithelium Cells Reveals Variant B Interacting Mitochondrial Proteins.
Carlsson E, Sharif U, Supharattanasitthi W, Paraoan L. Carlsson E, et al. Cells. 2023 Feb 23;12(5):713. doi: 10.3390/cells12050713. Cells. 2023. PMID: 36899848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical